Biologic data exclusivity in Vietnam: change is on the horizon

Data exclusivity protection for biologics in Vietnam will soon undergo some welcome changes due to the enactment of a new pharmaceutical law at the beginning of 2017, and the country’s increased involvement in trade agreements such as the Trans-Pacific Partnership (TPP) and the EU-Vietnam Free Trade Agreement (EVFTA). While the changes are expected to be small, they could have a noticeable impact on manufacturers of biologics.